You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Urine melatonin levels are inversely associated with sarcopenia in postmenopausal women

Lee, Jee-Yon MD1; Kim, Jung-Ha MD2; Lee, Duk-Chul MD, PhD1

Erratum

In the article appearing in volume 21, pages 39-44, of Menopause, entitled “Urine melatonin levels are inversely associated with sarcopenia in postmenopausal women”, there was an error in the Yonsei University grant funding 4-2011-0695. The funding should have been listed as:

6-2011-0202

Menopause. 21(5):550, May 2014.

Menopause:
doi: 10.1097/GME.0b013e318291f6c8
Original Articles
Abstract

Objective: Mainly secreted in the pineal gland, melatonin is a neurohormone that has versatile functions, including cellular protection. Decreased melatonin levels are associated with the aging process and age-related conditions. Melatonin may be associated with sarcopenia because it is one of the most common age-related diseases and because disrupted cellular vitality in skeletal muscle is known to be involved in its pathogenesis. Therefore, we investigated the relationship between first-morning-urine 6-sulfatoxymelatonin (aMT6s) levels and sarcopenia in Korean postmenopausal women.

Methods: Seventy-eight Korean postmenopausal women participated. Biomarkers of metabolic risk factors, along with the presence of sarcopenia, were assessed using dual-energy x-ray absorptiometry. Urine aMT6s levels were measured using enzyme-linked immunosorbent assay.

Results: The prevalence of sarcopenia increased significantly with increasing aMT6s quartiles. Furthermore, multivariate logistic regression analysis showed that the fourth aMT6s quartile was associated with sarcopenia, with an adjusted odds ratio of 0.13 (95% CI, 0.03-0.70; P = 0.02).

Conclusions: Our study shows an inverse association between urine melatonin and sarcopenia, suggesting that melatonin may have a protective role in the pathophysiology of sarcopenia. Further studies are required to better understand the clinical significance of our findings.

Author Information

From the 1Department of Family Medicine, Severance Hospital, College of Medicine, Yonsei University, Seodaemun-gu, Korea; and 2Department of Family Medicine, Chung-Ang University Medical Center, Dongjak-gu, Seoul, Korea.

Received December 10, 2012; revised and accepted March 4, 2013.

Funding/support: This study was partially supported by a research grant from Yonsei University College of Medicine (4-2011-0695).

Financial disclosure/conflicts of interest: None reported.

Address correspondence to: Duk-Chul Lee, MD, PhD, Department of Family Medicine, Severance Hospital, College of Medicine, Yonsei University, 250 Seongsanno, Seodaemun-gu 120-752, Korea. E-mail: faith@yuhs.ac

© 2014 by The North American Menopause Society.